+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Inovio Pharmaceuticals Inc - logo

Inovio Pharmaceuticals is a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. The company has developed antigen-targeting immunotherapy and vaccine product candidates for HPV-caused precancers and cancers, breast, lung, pancreatic, and prostate cancer, hepatitis, HIV, influenza, Ebola, and other diseases. Inovio was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

From
Human Immunodeficiency Virus (Hiv 1) Infection - Pipeline Insight, 2021 - Product Thumbnail Image

Human Immunodeficiency Virus (Hiv 1) Infection - Pipeline Insight, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
  • Global
From
From
From
From
Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030 - Product Thumbnail Image

Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030

  • Report
  • January 2020
  • 410 Pages
  • Global
From
Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 386 Pages
  • Global
From
From
Cervical Cancer Vaccine Global Market Report 2024 - Product Thumbnail Image

Cervical Cancer Vaccine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
COVID-19 Current Therapy Global Market Report 2024 - Product Thumbnail Image

COVID-19 Current Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
From
Loading Indicator